"What's In It for Me?" Taking PAT to the Executive Suite, Part 2

In this audio interview at his offices in Dublin, Paraic O'Toole, CEO of Automsoft, talks about the issues affecting PAT's future. Instead of thinking "technology," he says, corporate executives should view PAT as a tool to improve share prices and profitability. PhRMA could play a far more active role in educating the top brass, and FDA support, at the Commissioner level, would speed PAT's adoption.